Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5375-5382

  Kim, Yoon Keun ^a   Oh, Sun Young ^b   Jeon, Seong Gyu ^a   Park, Heung Woo ^c   Lee, Soo Yeon ^c   Chun, Eun Young ^c   Bang, Boram ^c   Lee, Hyun Seung ^c   Oh, Min Hee ^a   Kim, You Sun ^a   Kim, Jong Hoon ^d   Gho, Yong Song ^a   Cho, Sang Heon ^c   Min, Kyung Up ^c   Kim, You Young ^c   Zhu, Zhou ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Seoul National University College of Medicine   (South Korea)

^d Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MODEL; DISEASE SEVERITY; EOSINOPHILIA; EVALUATION; FEMALE; GENE; GENE MUTATION; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPUTUM; STAT4 GENE; SYMPTOM;

EID: 34247135082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5375     Document Type: Article

References (46)

1. Cutz, E., H. Levison, and D. M. Cooper. 1978. Ultrastructure of airways in children with asthma. Histopathology 2: 407-421.
2. Bochner, B. S., B. J. Undem, and L. M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 12: 295-335.
3. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
4. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
5. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
6. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
7. + T cells in asthma. Am. J. Respir. Crit. Care Med. 161: 1790-1796.
8. + T cells in atopic asthma. Am. J. Respir. Crit. Care Med. 171: 224-230.
9. Gereda, J. E., D. Y. Leung, A. Thatayatikom, J. E. Streib, M. R. Price, M. D. Klinnert, and A. H. Liu. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355: 1680-1683.
10. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032.
11. Braun-Fahrlander, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347: 869-877.
12. Gern, J. E. 2004. Viral respiratory infection and the link to asthma. Pediatr. Infect. Dis. J. 23: S78-86.
13. Michel, O., R. Ginanni, J. Duchateau, F. Vertongen, B. Le Bon, and R. Sergysels. 1991. Domestic endotoxin exposure and clinical severity of asthma. Clin. Exp. Allergy 21: 441-448.
14. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4: 471-481.
15. Kuipers, H., D. Hijdra, V. C. De Vries, H. Hammad, J. B. Prins, A. J. Coyle, H. C. Hoogsteden, and B. N. Lambrecht. 2003. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J. Immunol. 171: 3645-3654.
16. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651.
17. Kim, Y. K., S. H. Cho, Y. Y. Koh, J. W. Son, Y. K. Jee, M. H. Lee, K. U. Min, and Y. Y. Kim. 1999. Skin reactivity to inhalant allergens, total serum IgE levels, and bronchial responsiveness to methacholine are increased in parents of nonatopic asthmatic children. J. Allergy Clin. Immunol. 104: 311-316.
18. Bousquet, J. 2000. Global initiative for asthma (GINA) and its objectives. Clin. Exp. Allergy 30(Suppl. 1): 2-5.
19. Lee, C. G., H. Link, P. Baluk, R. J. Homer, S. Chapoval, V. Bhandari, M. J. Kang, L. Cohn, Y. K. Kim, D. M. McDonald, and J. A. Elias. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10: 1095-1103.
20. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
21. + T cells. J. Exp. Med. 177: 573-576.
22. Lack, G., K. L. Bradley, E. Hamelmann, H. Renz, J. Loader, D. Y. Leung, G. Larsen, and E. W. Gelfand. 1996. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J. Immunol. 157: 1432-1439.
23. Savelkoul, H. F., B. W. Seymour, L. Sullivan, and R. L. Coffman. 1991. IL-4 can correct defective IgE production in SJA/9 mice. J. Immunol. 146: 1801-1805.
24. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
25. Hessel, E. M., A. J. Van Oosterhout, I. Van Ark, B. Van Esch, G. Hofman, H. Van Loveren, H. F. Savelkoul, and F. P. Nijkamp. 1997. Development of airway hyperresponsiveness is dependent on interferon-γ and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16: 325-334.
26. Rankin, J. A., D. E. Picarella, G. P. Geba, U. A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93: 7821-7825.
27. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. F. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eostnophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356: 2144-2148.
28. Corrigan, C. J., and A. B. Kay. 1991. GD4 T lymphocyte activation in acute severe asthma. Int. Arch. Allergy Appl. Immunol. 94: 270-271.
29. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. F. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356: 2144-2148.
30. Bryan, S. A., B. J. O'Connor, S. Matti, M. J. Leckie, V. Kanabar, J. Khan, S. J. Warrington, L. Renzetti, A. Rames, J. A. Bock, et al. 2000. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2149-2153.
31. Ashwell, J. D., F. W. Lu, and M. S. Vacchio. 2000. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18: 309-345.
32. Louis, R., L. C. Lau, A. O. Bron, A. C. Roldaan, M. Radermecker, and R. Djukanovic. 2000. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 161: 9-16.
33. Vrugt, B., S. Wilson, J. Underwood, A. Bron, R. de Bruyn, P. Bradding, S. T. Holgate, R. Djukanovic, and R. Aalbers. 1999. Mucosal inflammation in severe glucocorticoid-dependent asthma. Eur. Respir. J. 13: 1245-1252.
34. Wang, Z., T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman, Jr., S. D. Shapiro, and J. A. Elias. 2000. Interferon γ induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192: 1587-1600.
35. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β 1. J. Exp. Med. 194: 809-821.
36. Wenzel, S. E., L. B. Schwartz, E. L. Langmack, J. L. Halliday, J. B. Trudeau, R. L. Gibbs, and H. W. Chu. 1999. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 160: 1001-1008.
37. Neurath, M. F., S. Finotto, and L. H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8: 567-573.
38. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
39. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527-1536.
40. Szabo, S. J., B. M. Sullivan, S. L. Peng, and L. H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758.
41. Siraganian, R. P., H. Baer, H. D. Hochstein, and J. C. May. 1979. Allergenic and biologic activity of commercial preparations of house dust extract. J. Allergy Clin. Immunol. 64: 526-533.
42. Michel, O., J. Kips, J. Duchateau, F. Vertongen, L. Robert, H. Collet, R. Pauwels, and R. Sergysels. 1996. Severity of asthma is related to endotoxin in house dust. Am. J. Respir. Crit. Care Med. 154: 1641-1646.
43. Dahl, M. E., K. Dabbagh, D. Liggitt, S. Kim, and D. B. Lewis. 2004. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 5: 337-343.
44. Park, J. H., D. R. Gold, D. L. Spiegelman, H. A. Burge, and D. K. Milton. 2001. House dust endotoxin and wheeze in the first year of life. Am. J. Respir. Crit. Care Med. 163: 322-328.
45. Hogg, J. C. 1999. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 160: S26-S28.
46. Olenchock, S. A., J. J. May, D. S. Pratt, and P. R. Morey. 1987. Occupational exposures to airborne endotoxins in agriculture. Prog. Clin. Biol. Res. 231: 475-487.